10,11-methylenedioxy-20-camptothecin has been researched along with aphidicolin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bertrand, R; Goldman, J; Kerrigan, D; Kohn, KW; Nieves-Neira, W; O'Connor, PM; Pommier, Y | 1 |
1 other study(ies) available for 10,11-methylenedioxy-20-camptothecin and aphidicolin
Article | Year |
---|---|
S-phase population analysis does not correlate with the cytotoxicity of camptothecin and 10,11-methylenedioxycamptothecin in human colon carcinoma HT-29 cells.
Topics: Animals; Aphidicolin; Camptothecin; Cell Division; Cell Line; Cell Survival; Colonic Neoplasms; Diterpenes; DNA Polymerase II; DNA Replication; DNA, Neoplasm; Humans; Molecular Structure; S Phase; Topoisomerase I Inhibitors; Tumor Cells, Cultured | 1991 |